hVIVO plc (LON:HVO)
6.90p-4.83%
Spriggl Score: Poor— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Niche leader with validated challenge models and net cash; cyclical revenue trough sets up a contract-driven recovery.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About hVIVO plc
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including …
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- £58.2M
Recent dividends
- 15 May 20250.20p
- 18 Apr 20240.20p
- 4 May 20230.45p(special)
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across hVIVO plc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free